80 related articles for article (PubMed ID: 32826307)
1. COVID-19 in patients with cirrhosis: understanding adverse impact.
Sharma S; Elhence A; Vaishnav M; Kumar R; Shalimar
Gut; 2021 Jul; 70(7):1409. PubMed ID: 32826307
[No Abstract] [Full Text] [Related]
2. Liver fibrosis and adverse outcomes in COVID-19.
Huang J
Dig Liver Dis; 2021 Jul; 53(7):799. PubMed ID: 33994131
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
4. The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research.
Gao F; Huang ZM
J Hepatol; 2020 Dec; 73(6):1568-1569. PubMed ID: 32574579
[No Abstract] [Full Text] [Related]
5. A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019.
Attauabi M; Burisch J; Bendtsen F; Kimer N
Scand J Gastroenterol; 2021 Apr; 56(4):453-457. PubMed ID: 33590789
[TBL] [Abstract][Full Text] [Related]
6. Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Lampertico P
Gut; 2021 Sep; 70(9):1798-1799. PubMed ID: 33028665
[No Abstract] [Full Text] [Related]
7. COVID-19 in a Patient with Liver Cirrhosis.
Kreivenaite E; Gedgaudas R; Valantiene I; Mickiene A; Kupcinskas J
J Gastrointestin Liver Dis; 2020 Jun; 29(2):263-266. PubMed ID: 32530994
[TBL] [Abstract][Full Text] [Related]
8. ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.
Gao F; Zheng KI; Fan YC; Targher G; Byrne CD; Zheng MH
Am J Gastroenterol; 2020 Sep; 115(9):1544. PubMed ID: 32694292
[No Abstract] [Full Text] [Related]
9. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.
Xiao Y; Wu D; Shi X; Liu S; Hu X; Zhou C; Tian X; Liu H; Long H; Li Z; Wang J; Tan T; Xu Y; Chen B; Liu T; Zhang H; Zheng S; Hu S; Song J; Tang J; Song J; Cheng Z; Xu W; Shen Y; Yu W; Xu Y; Li J; Zhou J; Wang F; Chen M
Virulence; 2021 Dec; 12(1):1199-1208. PubMed ID: 33870852
[No Abstract] [Full Text] [Related]
10. Reply to: "Liver fibrosis and adverse outcomes in COVID-19".
Ruiz-Margáin A; Campos-Murguía A; González-Regueiro JA; Román-Calleja BM; Delint DK; Macías-Rodríguez RU
Dig Liver Dis; 2021 Jul; 53(7):800. PubMed ID: 33947641
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis.
Kulkarni AV; Metage CS; Gora BA; Tirumalle S; Rakam K; Satyavadi A; Sharma M; Shaik S; Gujjarlapudi D; Rao PN; Reddy DN
Gut; 2023 Oct; 72(10):1995-1996. PubMed ID: 36113980
[No Abstract] [Full Text] [Related]
12. Reply to: Correspondence on "High rates of 30-day mortality in patients with cirrhosis and COVID-19".
Iavarone M; D'Ambrosio R; Lampertico P;
J Hepatol; 2020 Dec; 73(6):1570-1571. PubMed ID: 32771429
[No Abstract] [Full Text] [Related]
13. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
14. Letter regarding "High rates of 30-day mortality in patients with cirrhosis and COVID-19".
Medhat MA; El Kassas M
J Hepatol; 2020 Dec; 73(6):1569-1570. PubMed ID: 32574577
[No Abstract] [Full Text] [Related]
15. Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.
Xiao Y; Pan H; She Q; Wang F; Chen M
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):528-529. PubMed ID: 32197093
[No Abstract] [Full Text] [Related]
16. Trends in cirrhosis hospitalizations during the COVID-19 pandemic.
Gaspar R; Liberal R; Branco CC; Macedo G
Dig Liver Dis; 2020 Sep; 52(9):942-943. PubMed ID: 32680758
[No Abstract] [Full Text] [Related]
17. Correspondence on "prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection".
Mungmunpuntipantip R; Wiwanitkit V
Ann Hepatol; 2021; 25():100360. PubMed ID: 34119682
[No Abstract] [Full Text] [Related]
18. Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work?
Calleri A; Saracco M; Romagnoli R; Martini S
Hepatol Commun; 2022 Jun; 6(6):1502-1503. PubMed ID: 35429145
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.
Qi X; Liu Y; Wang J; Fallowfield JA; Wang J; Li X; Shi J; Pan H; Zou S; Zhang H; Chen Z; Li F; Luo Y; Mei M; Liu H; Wang Z; Li J; Yang H; Xiang H; Li X; Liu T; Zheng MH; Liu C; Huang Y; Xu D; Li X; Kang N; He Q; Gu Y; Zhang G; Shao C; Liu D; Zhang L; Li X; Kawada N; Jiang Z; Wang F; Xiong B; Takehara T; Rockey DC;
Gut; 2021 Feb; 70(2):433-436. PubMed ID: 32434831
[No Abstract] [Full Text] [Related]
20. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care.
Tapper EB; Asrani SK
J Hepatol; 2020 Aug; 73(2):441-445. PubMed ID: 32298769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
